History of combined protection: 25 years of using the fixed-dose combination of amlodipine and bisoprolol in clinical practice

Abstract

The paper discusses the role of Concor AM, the fixed-dose combination of amlodipine and bisoprolol, which has been used in clinical practice for treatment of patients with cardiovascular diseases for 25 years. The data are provided on the benefits of using Concor AM in treatment of patients with arterial hypertension and coronary artery disease. Evidence is discussed that illustrated the advantages of using such fixed-dose combination compared to the combination use of amlodipine and bisoprolol in the form of the so-called free combination. The evidence also includes the results of the recently completed randomized clinical trial that involved comparative analysis of the use of Concor AM and irbesartan monotherapy as part of the initial strategy for antihypertensive therapy. The role of each component of Concor AM in modern therapy for patients with cardiovascular diseases is considered.

Keywords

• amlodipine
• bisoprolol
• combination therapy
• arterial hypertension